REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

SSY Group Limited (Hong Kong SAR, China)

Main Activities: Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing
Full name: SSY Group Limited Profile Updated: March 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Principally engaged in the research, development, manufacturing and selling of a wide range of finished medicines and bulk pharmaceutical products to hospitals and distributors. The Group has manufacturing plants in Hebei Province and Shaanxi Province, the People＇s Republic of China (“PRC”; “Mainland China”), and sells to customers mainly in Mainland China.

Headquarters
Rooms 4902-03, 49th Floor, Central Plaza, 18 Harbour Road, Wanchai, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the SSY Group Limited report to view the information.

Website: http://www.ssygroup.com.hk

Basic Information
Total Employees:
Purchase the SSY Group Limited report to view the information.
Outstanding Shares:
Purchase the SSY Group Limited report to view the information.
Registered Capital:
Purchase the SSY Group Limited report to view the information.
Financial Auditors:
Purchase the SSY Group Limited report to view the information.
Incorporation Date:
September 28, 2004
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
26.79%
Purchase this report to view the information.
14.96%
Purchase this report to view the information.
9.3%
Purchase this report to view the information.
5.35%
Purchase this report to view the information.
Subsidiaries
Hebei Guangxiang Pharmaceutical Technology Co., Ltd. (China)
100%
Hebei Guolong Pharmaceutical Co., Ltd. (China)
100%
Hebei Jinmen Pharmaceutical Import & Export Co., Ltd. (China)
100%
Company Performance
Financial values in the chart are available after SSY Group Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
0.45%▲
Total operating revenue
3.24%▲
Operating profit (EBIT)
13.28%▲
EBITDA
13.25%▲
Net Profit (Loss) for the Period
11.75%▲
Total assets
9.12%▲
Total equity
11.04%▲
Operating Profit Margin (ROS)
2.92%▲
Net Profit Margin
2.08%▲
Return on Equity (ROE)
0.12%▲
Debt to Equity Ratio
-2.61%▼
Quick Ratio
0.08%▲
Cash Ratio
-0.02%▼

Similar companies

Sinopharm Group Company Limited
 
China Resources Pharmaceutical Group Ltd
Fosun International Limited
 
China Risun Group Limited (Beijing) (中国旭阳集团有限公司 (北京))
Kingboard Holdings Limited
 
CSPC Pharmaceutical Group Limited
Tianhe Chemicals Group Limited
 
Lee & Man Chemical Company Limited
Innovent Biologics, Inc.
 
Lam Soon Hong Kong Limited
Dingdang Health Technology Group Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo